Cargando…

Compatibility of Injectable Anticoagulant Agents in Ethanol; In Vitro Antibiofilm Activity and Impact on Polyurethane Catheters of Enoxaparin 400 U/mL in 40% v/v Ethanol

BACKGROUND AND OBJECTIVES: Interdialytic lock solutions should maintain catheter patency and prevent catheter infections. We aimed to determine in which conditions injectable anticoagulant agents (IAAs) combined with ethanol are compatible and to assess the antibiofilm activity of the selected combi...

Descripción completa

Detalles Bibliográficos
Autores principales: Balestrino, Damien, Quintana, Mercédès, Charbonnel, Nicolas, Forestier, Christiane, Lartigue, Claire, Souweine, Bertrand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4956118/
https://www.ncbi.nlm.nih.gov/pubmed/27441664
http://dx.doi.org/10.1371/journal.pone.0159475
_version_ 1782443985811275776
author Balestrino, Damien
Quintana, Mercédès
Charbonnel, Nicolas
Forestier, Christiane
Lartigue, Claire
Souweine, Bertrand
author_facet Balestrino, Damien
Quintana, Mercédès
Charbonnel, Nicolas
Forestier, Christiane
Lartigue, Claire
Souweine, Bertrand
author_sort Balestrino, Damien
collection PubMed
description BACKGROUND AND OBJECTIVES: Interdialytic lock solutions should maintain catheter patency and prevent catheter infections. We aimed to determine in which conditions injectable anticoagulant agents (IAAs) combined with ethanol are compatible and to assess the antibiofilm activity of the selected combination and its effects on dialysis catheters (DC). METHODS: The solubility and compatibility of unfractionated heparin (UFH), low molecular weight heparins (LMWHs), heparinoids and fondaparinux (50 to 2,500 U/mL) in 30 to 70% ethanol were determined by visual observation. The stability of enoxaparin in ethanol and the ethanol content were assessed by high performance liquid chromatography (HPLC) and titrimetric control, respectively. The bactericidal effect was determined on 24h-old biofilms embedded in silicone-DC. The integrity of polyurethane-DC immersed in anticoagulant-ethanol was assessed by gas chromatography-mass spectrometry (GC-MS) and compared with previously published results. RESULTS: The compatibility of IAAs and ethanol varied according to IAA type and concentration, and ethanol content. UFH in 40% ethanol was not compatible, whatever the UFH concentration used. Established limits of compatibility of enoxaparin, nadroparin, dalteparin and tinzaparin in 40% ethanol were 1350, 575, 307 and 207 U/ml, respectively, and up to 300 U/ml for danaparoid and 1 mg/mL for fondaparinux. Enoxaparin 400 U/mL in 40% ethanol (Enox/Eth) eradicated biofilm after 4 hours of exposure for Staphylococcus epidermidis, Pseudomonas aeruginosa and Candida albicans and after 24 hours for Klebsiella pneumoniae and S. aureus. Aliphatic carbonate and alcohol compounds were released by polyurethane-DC after Enox/Eth exposure, as after 40% ethanol or saline exposure. There was no significant difference between the amounts released after 30 minutes of exposure to Enox/Eth and 15 days to saline. CONCLUSIONS: A 40% ethanol solution can be combined with all IAAs but UFH. Enox/Eth was effective as an anti-biofilm agent with minor impacts on DC integrity and could be a useful interdialytic lock solution.
format Online
Article
Text
id pubmed-4956118
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-49561182016-08-08 Compatibility of Injectable Anticoagulant Agents in Ethanol; In Vitro Antibiofilm Activity and Impact on Polyurethane Catheters of Enoxaparin 400 U/mL in 40% v/v Ethanol Balestrino, Damien Quintana, Mercédès Charbonnel, Nicolas Forestier, Christiane Lartigue, Claire Souweine, Bertrand PLoS One Research Article BACKGROUND AND OBJECTIVES: Interdialytic lock solutions should maintain catheter patency and prevent catheter infections. We aimed to determine in which conditions injectable anticoagulant agents (IAAs) combined with ethanol are compatible and to assess the antibiofilm activity of the selected combination and its effects on dialysis catheters (DC). METHODS: The solubility and compatibility of unfractionated heparin (UFH), low molecular weight heparins (LMWHs), heparinoids and fondaparinux (50 to 2,500 U/mL) in 30 to 70% ethanol were determined by visual observation. The stability of enoxaparin in ethanol and the ethanol content were assessed by high performance liquid chromatography (HPLC) and titrimetric control, respectively. The bactericidal effect was determined on 24h-old biofilms embedded in silicone-DC. The integrity of polyurethane-DC immersed in anticoagulant-ethanol was assessed by gas chromatography-mass spectrometry (GC-MS) and compared with previously published results. RESULTS: The compatibility of IAAs and ethanol varied according to IAA type and concentration, and ethanol content. UFH in 40% ethanol was not compatible, whatever the UFH concentration used. Established limits of compatibility of enoxaparin, nadroparin, dalteparin and tinzaparin in 40% ethanol were 1350, 575, 307 and 207 U/ml, respectively, and up to 300 U/ml for danaparoid and 1 mg/mL for fondaparinux. Enoxaparin 400 U/mL in 40% ethanol (Enox/Eth) eradicated biofilm after 4 hours of exposure for Staphylococcus epidermidis, Pseudomonas aeruginosa and Candida albicans and after 24 hours for Klebsiella pneumoniae and S. aureus. Aliphatic carbonate and alcohol compounds were released by polyurethane-DC after Enox/Eth exposure, as after 40% ethanol or saline exposure. There was no significant difference between the amounts released after 30 minutes of exposure to Enox/Eth and 15 days to saline. CONCLUSIONS: A 40% ethanol solution can be combined with all IAAs but UFH. Enox/Eth was effective as an anti-biofilm agent with minor impacts on DC integrity and could be a useful interdialytic lock solution. Public Library of Science 2016-07-21 /pmc/articles/PMC4956118/ /pubmed/27441664 http://dx.doi.org/10.1371/journal.pone.0159475 Text en © 2016 Balestrino et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Balestrino, Damien
Quintana, Mercédès
Charbonnel, Nicolas
Forestier, Christiane
Lartigue, Claire
Souweine, Bertrand
Compatibility of Injectable Anticoagulant Agents in Ethanol; In Vitro Antibiofilm Activity and Impact on Polyurethane Catheters of Enoxaparin 400 U/mL in 40% v/v Ethanol
title Compatibility of Injectable Anticoagulant Agents in Ethanol; In Vitro Antibiofilm Activity and Impact on Polyurethane Catheters of Enoxaparin 400 U/mL in 40% v/v Ethanol
title_full Compatibility of Injectable Anticoagulant Agents in Ethanol; In Vitro Antibiofilm Activity and Impact on Polyurethane Catheters of Enoxaparin 400 U/mL in 40% v/v Ethanol
title_fullStr Compatibility of Injectable Anticoagulant Agents in Ethanol; In Vitro Antibiofilm Activity and Impact on Polyurethane Catheters of Enoxaparin 400 U/mL in 40% v/v Ethanol
title_full_unstemmed Compatibility of Injectable Anticoagulant Agents in Ethanol; In Vitro Antibiofilm Activity and Impact on Polyurethane Catheters of Enoxaparin 400 U/mL in 40% v/v Ethanol
title_short Compatibility of Injectable Anticoagulant Agents in Ethanol; In Vitro Antibiofilm Activity and Impact on Polyurethane Catheters of Enoxaparin 400 U/mL in 40% v/v Ethanol
title_sort compatibility of injectable anticoagulant agents in ethanol; in vitro antibiofilm activity and impact on polyurethane catheters of enoxaparin 400 u/ml in 40% v/v ethanol
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4956118/
https://www.ncbi.nlm.nih.gov/pubmed/27441664
http://dx.doi.org/10.1371/journal.pone.0159475
work_keys_str_mv AT balestrinodamien compatibilityofinjectableanticoagulantagentsinethanolinvitroantibiofilmactivityandimpactonpolyurethanecathetersofenoxaparin400umlin40vvethanol
AT quintanamercedes compatibilityofinjectableanticoagulantagentsinethanolinvitroantibiofilmactivityandimpactonpolyurethanecathetersofenoxaparin400umlin40vvethanol
AT charbonnelnicolas compatibilityofinjectableanticoagulantagentsinethanolinvitroantibiofilmactivityandimpactonpolyurethanecathetersofenoxaparin400umlin40vvethanol
AT forestierchristiane compatibilityofinjectableanticoagulantagentsinethanolinvitroantibiofilmactivityandimpactonpolyurethanecathetersofenoxaparin400umlin40vvethanol
AT lartigueclaire compatibilityofinjectableanticoagulantagentsinethanolinvitroantibiofilmactivityandimpactonpolyurethanecathetersofenoxaparin400umlin40vvethanol
AT souweinebertrand compatibilityofinjectableanticoagulantagentsinethanolinvitroantibiofilmactivityandimpactonpolyurethanecathetersofenoxaparin400umlin40vvethanol